chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: RV5
Symptoms: Product storage error
Clinical narrative: No additional adverse event (AE); ROTATEQ  was administered after temperature excursion; This spontaneous report was received from a medical assistant and refers to an unknown age and gender patient.    The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant therapies were not reported.  On 14-AUG-2023, the suspect vaccine was exposed to a temperature of 8.9 degree Celsius for a time frame of 12 hours 20 minutes 0 seconds. On 28-AUG-2023, the suspect vaccine was exposed to a temperature of 9.4 degree Celsius  for a time frame 8 hours 20 minutes 0 seconds. No previous temperature excursion occurred.   On 13-SEP-2023, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, one dosage form, lot #1968393 was verified to be a valid number, expiration date reported and established as 24-MAY-2024), administered orally for prophylaxis (strength was not provided) (product storage error). No additional adverse event was provided.
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Muscle tightness, Neuropathy peripheral
Clinical narrative: NEUROPATHY ISSUES; EQUILIBRIUM ISSUES; TIGHTNESS IN LEGS; This spontaneous report received from a consumer concerned a male of unspecified age, race and ethnic origin. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, 1 total, administered on 18-APR-2021 for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced neuropathy issues, but it was not confirmed if patient had neuropathy prior to the vaccine or not. Patient complains about equilibrium issues and tightness in his legs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the neuropathy issues, equilibrium issues and tightness in legs was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20231019612.; Sender's Comments: V0:20231019738-neuropathy issues. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.
Sex: F
Vaccine: COVID19-2
Symptoms: Autoimmune thyroiditis
Clinical narrative: Hashimoto's autoimmune disease; This spontaneous case was reported by a consumer and describes the occurrence of AUTOIMMUNE THYROIDITIS (Hashimoto's autoimmune disease) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Concurrent medical conditions included Thyroid disorder NOS.    In November 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced AUTOIMMUNE THYROIDITIS (Hashimoto's autoimmune disease) (seriousness criterion medically significant). At the time of the report, AUTOIMMUNE THYROIDITIS (Hashimoto's autoimmune disease) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Patient stated that she had Hashimoto's Autoimmune Disease and she's taking Thyroid Synergy, a non-FDA approved supplement for her thyroid problem. She's also taking gluten free diet. The problem had been there all along even before she took the 1st Moderna dose, but the diagnosis of Hashimoto's autoimmune disease was only made this year.  Company Comment This spontaneous case concerns an female patient of unknown age with medical history of Thyroid disorder who experienced the seriousness criteria medically significant unexpected AESI of autoimmune thyroiditis unknown days after MODERNA COVID-19 VACCINE, BIVALENT ORIGINAL AND OMICRON BA.4/BA.5 vaccine. The problem had been there even before she took the 1st Moderna dose, but the diagnosis of Hashimoto's autoimmune disease was only made this year. The medical history is a confounder for the event. The benefit-risk relationship of MODERNA COVID-19 VACCINE, BIVALENT ORIGINAL AND OMICRON BA.4/BA.5 vaccine is not affected by this report.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Headache, Injection site pain, Myalgia, Sleep disorder
Clinical narrative: In addition to pain at the injection site, I developed headache and muscle pain on Oct 12, 2023.  I slept only fitfully that night.  When I got up on Oct 13, I felt as though my head was pounding.  I took my blood pressure before breakfast at 6:30 am.  It was elevated: 147/67 and my heart rate was 105.
Age: 33.0
Sex: F
Vaccine: FLU4
Symptoms: Pruritus, Urticaria
Clinical narrative: Onset of itching to various areas of body with small, but prominent hives to distal right arm, chest, neck.  Onset within 20-25 minutes.  No history of reaction in the past to vaccine, tape, or alcohol rub.  OTC antihistamines and monitor
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Computerised tomogram abdomen abnormal, Computerised tomogram thorax normal, Death
Clinical narrative: admitted  for shock liver and COVID-19 infection. Treatment for COVID was not indicated as patient did not have any significant symptoms or hypoxia; Tx: Eliquis x2 days, then lovenox, doxycycline, singulair,  improved over the next 3-4 days, with LFTs coming down each day. However, on 02/01, patient persistently hypotensive despite multiple IV fluid boluses. Her RBC dropping, so blood transfusion was ordered; condition continued to deteriorate, transferred to ICU requiring pressors; intubated and MTP was initiated as she continued to have dropping blood count despite blood transfusion. Stat CT abd/pelvis showed a large retroperitoneal hematoma. Initial CT abd/chest done 3 days prior had been unremarkable with no signs of bleeding. She was evaluated by IR to assess for possible embolization, however access to the bleed was not possible. Family eventually changed patient's code status to DNR. family decided on withdrawal of care. Patient passed away shortly afterwards.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Endotracheal intubation, Full blood count abnormal, General physical health deterioration, Hypotension, Intensive care
Clinical narrative: admitted  for shock liver and COVID-19 infection. Treatment for COVID was not indicated as patient did not have any significant symptoms or hypoxia; Tx: Eliquis x2 days, then lovenox, doxycycline, singulair,  improved over the next 3-4 days, with LFTs coming down each day. However, on 02/01, patient persistently hypotensive despite multiple IV fluid boluses. Her RBC dropping, so blood transfusion was ordered; condition continued to deteriorate, transferred to ICU requiring pressors; intubated and MTP was initiated as she continued to have dropping blood count despite blood transfusion. Stat CT abd/pelvis showed a large retroperitoneal hematoma. Initial CT abd/chest done 3 days prior had been unremarkable with no signs of bleeding. She was evaluated by IR to assess for possible embolization, however access to the bleed was not possible. Family eventually changed patient's code status to DNR. family decided on withdrawal of care. Patient passed away shortly afterwards.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Ischaemic hepatitis, Liver function test abnormal, Red blood cell count decreased, Retroperitoneal haematoma, Transfusion
Clinical narrative: admitted  for shock liver and COVID-19 infection. Treatment for COVID was not indicated as patient did not have any significant symptoms or hypoxia; Tx: Eliquis x2 days, then lovenox, doxycycline, singulair,  improved over the next 3-4 days, with LFTs coming down each day. However, on 02/01, patient persistently hypotensive despite multiple IV fluid boluses. Her RBC dropping, so blood transfusion was ordered; condition continued to deteriorate, transferred to ICU requiring pressors; intubated and MTP was initiated as she continued to have dropping blood count despite blood transfusion. Stat CT abd/pelvis showed a large retroperitoneal hematoma. Initial CT abd/chest done 3 days prior had been unremarkable with no signs of bleeding. She was evaluated by IR to assess for possible embolization, however access to the bleed was not possible. Family eventually changed patient's code status to DNR. family decided on withdrawal of care. Patient passed away shortly afterwards.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, C-reactive protein, COVID-19, Chest X-ray abnormal, Fibrin D dimer
Clinical narrative: Presented with worsening covid symptoms; initial + covid 2 weeks prior; CXR: bilat PNA; Labs: D-dimer 1.23; CRP 8.08, Ferritin 268; Tx: Maxipime, Decadron, Lovenox; No remdesivir due to out of range; Initially on 2 LPM O2, up to 5 LPM during visit, back down to 2LPM at d/c; home with O2
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pneumonia, SARS-CoV-2 test positive, Serum ferritin increased
Clinical narrative: Presented with worsening covid symptoms; initial + covid 2 weeks prior; CXR: bilat PNA; Labs: D-dimer 1.23; CRP 8.08, Ferritin 268; Tx: Maxipime, Decadron, Lovenox; No remdesivir due to out of range; Initially on 2 LPM O2, up to 5 LPM during visit, back down to 2LPM at d/c; home with O2
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Asthenia, Blood lactic acid, C-reactive protein increased, Chest X-ray normal
Clinical narrative: Presented with weakness/hypotension; Labs: D-dimer 1.17; CRP 4.82; Lactic Acid normal; CXR  clear; Tx: Maxpime, lovenox, Remdesivir, Decadron, singulair, zinc; minimal O2 @ 2 LPM during stay; down to room air at d/c
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Hypotension
Clinical narrative: Presented with weakness/hypotension; Labs: D-dimer 1.17; CRP 4.82; Lactic Acid normal; CXR  clear; Tx: Maxpime, lovenox, Remdesivir, Decadron, singulair, zinc; minimal O2 @ 2 LPM during stay; down to room air at d/c
Age: 74.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: COVID-19, Orthostatic hypotension, Peripheral venous disease, SARS-CoV-2 test positive
Clinical narrative: Presentees with orthostatic hypotension and + covid; Tx: Rocephin, decadron, Sinulair; usual 20 mg of lisinopril was decreased to 5-10 mg, given IV fluids, stabilized with this. His orthostasis resolved, is ambulatory, his Covid remains stable does not require supplemental oxygen. saturations are holding in the 91-92% saturated range which is his usual. No new complications are seen, his chronic venous stasis changes are unchanged, no new clots are noted, his protime accelerates felt related to his Covid and his Coumadin is held this time but will restart in 2 days.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Asthenia, Blood creatinine abnormal, Blood electrolytes abnormal, COVID-19
Clinical narrative: presents with c/o abdominal pain, nausea and vomiting, generalized weakness, and fatigue; pt hyperkalemic and small SBO; + covid; did not require any supplemental oxygen and chest x-ray did not show any infiltrates. He was continued on supportive care; creatinine and other electrolytes normalized and d/c with HH
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray normal, Fatigue, Hyperkalaemia, Nausea, SARS-CoV-2 test positive
Clinical narrative: presents with c/o abdominal pain, nausea and vomiting, generalized weakness, and fatigue; pt hyperkalemic and small SBO; + covid; did not require any supplemental oxygen and chest x-ray did not show any infiltrates. He was continued on supportive care; creatinine and other electrolytes normalized and d/c with HH
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Small intestinal obstruction, Vomiting
Clinical narrative: presents with c/o abdominal pain, nausea and vomiting, generalized weakness, and fatigue; pt hyperkalemic and small SBO; + covid; did not require any supplemental oxygen and chest x-ray did not show any infiltrates. He was continued on supportive care; creatinine and other electrolytes normalized and d/c with HH
Age: 79.0
Sex: M
Vaccine: FLU4
Symptoms: Wrong product administered
Clinical narrative: Incorrect vaccine given at administration - should have received Fluad
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory distress syndrome, Acute respiratory failure, COVID-19, Cardio-respiratory arrest, Dyspnoea
Clinical narrative: Presented to ER with c/o SOB, + Covid 19 2 weeks prior to admission. Admitted for acute on chronic respiratory failure secondary to Covid-19.  Patients course was complicated by development of progressive hypoxemia which required high-flow nasal cannula, transferred to ICU, intubated. Required vasopressors, developed ARDS, required blood transfusions for GI bleed. Had a Code Blue arrest on 2/18/22, CPR 11 minutes, brother wished to transition to comfort care.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Endotracheal intubation, Gastrointestinal haemorrhage, Hypoxia, Intensive care, Resuscitation
Clinical narrative: Presented to ER with c/o SOB, + Covid 19 2 weeks prior to admission. Admitted for acute on chronic respiratory failure secondary to Covid-19.  Patients course was complicated by development of progressive hypoxemia which required high-flow nasal cannula, transferred to ICU, intubated. Required vasopressors, developed ARDS, required blood transfusions for GI bleed. Had a Code Blue arrest on 2/18/22, CPR 11 minutes, brother wished to transition to comfort care.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Transfusion
Clinical narrative: Presented to ER with c/o SOB, + Covid 19 2 weeks prior to admission. Admitted for acute on chronic respiratory failure secondary to Covid-19.  Patients course was complicated by development of progressive hypoxemia which required high-flow nasal cannula, transferred to ICU, intubated. Required vasopressors, developed ARDS, required blood transfusions for GI bleed. Had a Code Blue arrest on 2/18/22, CPR 11 minutes, brother wished to transition to comfort care.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Death, Intestinal perforation, Peritonitis, Sepsis
Clinical narrative: Patient had pneumonia related to covid, severe sepsis related to perforated bowel with peritonitis and covid pneumonia.  Patient was transitioned to inpatient hospice and passed away on 2.12.22.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Asthenia, Blood sodium decreased, C-reactive protein increased, COVID-19
Clinical narrative: Presented with weakness, mild SOB, hyponatremia; + Covid; CXR wiht trace pleural effusion; Ferritin and CRP slightly elevated; Tx, Merrem, Vit C, Decadron, Lovenox; Remained on room air throughout stay; sodium persistently remain lower side.  Ultimately patient's sodium was up to 130 and she was discharged to home in stable condition.  She was believed to have hyponatremia related to SIADH
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Dyspnoea, Hyponatraemia, Inappropriate antidiuretic hormone secretion, Pleural effusion
Clinical narrative: Presented with weakness, mild SOB, hyponatremia; + Covid; CXR wiht trace pleural effusion; Ferritin and CRP slightly elevated; Tx, Merrem, Vit C, Decadron, Lovenox; Remained on room air throughout stay; sodium persistently remain lower side.  Ultimately patient's sodium was up to 130 and she was discharged to home in stable condition.  She was believed to have hyponatremia related to SIADH
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Serum ferritin increased
Clinical narrative: Presented with weakness, mild SOB, hyponatremia; + Covid; CXR wiht trace pleural effusion; Ferritin and CRP slightly elevated; Tx, Merrem, Vit C, Decadron, Lovenox; Remained on room air throughout stay; sodium persistently remain lower side.  Ultimately patient's sodium was up to 130 and she was discharged to home in stable condition.  She was believed to have hyponatremia related to SIADH
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Asthenia, C-reactive protein normal, Chest X-ray normal, Dyspnoea
Clinical narrative: Presented with SOB/weakness; CXR clear;  Labs: D-dimer 2.97, CRP 0.40, Ferritin 181 Tx: with Decadron, Rocephin, Lovenox, Remdesivir, Vit C, Zithromax, Vit D3, Singulair, Zinc; initially on 2 lpm o2, down to room air by d/c
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Serum ferritin normal
Clinical narrative: Presented with SOB/weakness; CXR clear;  Labs: D-dimer 2.97, CRP 0.40, Ferritin 181 Tx: with Decadron, Rocephin, Lovenox, Remdesivir, Vit C, Zithromax, Vit D3, Singulair, Zinc; initially on 2 lpm o2, down to room air by d/c
Age: 36.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: Tinnitus
Clinical narrative: Tinnitus
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Body temperature increased, Computerised tomogram, Hypotension, Intensive care
Clinical narrative: 104F temperature, non-responsive, vomiting, very low blood pressure, sepsis physiology (no infection found)
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Lumbar puncture, Magnetic resonance imaging, Sepsis, Unresponsive to stimuli, Urine analysis
Clinical narrative: 104F temperature, non-responsive, vomiting, very low blood pressure, sepsis physiology (no infection found)
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: 104F temperature, non-responsive, vomiting, very low blood pressure, sepsis physiology (no infection found)
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness, Pain
Clinical narrative: ARM WEAKNESS, PAIN
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, C-reactive protein increased, COVID-19, Chest X-ray abnormal, Dyspnoea
Clinical narrative: Presented with gen weakness, dyspnea; + covid  Labs: D-dimer 0.79, CRP 2.95, Ferritin 1288 CXR: RLL PNA  Tx: Decadron, singulair; Rocephin,  no remdisivir due to unknown time of symptom onset; home with O2 for ambulation
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Pneumonia, SARS-CoV-2 test positive, Serum ferritin increased
Clinical narrative: Presented with gen weakness, dyspnea; + covid  Labs: D-dimer 0.79, CRP 2.95, Ferritin 1288 CXR: RLL PNA  Tx: Decadron, singulair; Rocephin,  no remdisivir due to unknown time of symptom onset; home with O2 for ambulation
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray normal, Confusional state, SARS-CoV-2 test positive
Clinical narrative: Presented with weakness, confusion; + Covid, + UTI, CXR: no PNA; Tx: Rocephin, remained on 3 LPM NC during stay; back to baseline at d/c
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: Presented with weakness, confusion; + Covid, + UTI, CXR: no PNA; Tx: Rocephin, remained on 3 LPM NC during stay; back to baseline at d/c
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Gastrointestinal disorder, Nausea, Vomiting
Clinical narrative: Patient presented to ER with c/o nausea and vomiting, diagnosed with Covid 19. GI symptoms related to Covid-19. Given IVF and antiemetics.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Confusional state, Dementia, Encephalopathy
Clinical narrative: Patient presented with increased confusion, diagnosed with encephalopathy from Covid-19 infection aggravated by dementia. Supportive care with Vitamin C, Decadron, Lovenox, and Zinc. Discharged on Hospice.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19, Cerebrovascular accident
Clinical narrative: Covid-19 Breakthrough Infection
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, COVID-19, Chest X-ray normal, Metabolic encephalopathy, SARS-CoV-2 test positive
Clinical narrative: Patient presented with afib w/ RVR, acute metabolic encephalopathy, found to be Covid + in ER, Covid-19 infection likely contributory to symptoms. CXR no acute findings. Vitamin C, Budesonide.
Age: 53.0
Sex: F
Vaccine: FLU4
Symptoms: Chills, Fatigue, Hyperhidrosis, Myalgia, Somnolence
Clinical narrative: muscle aches, chills, sweats, fatigue, drowsiness
Age: 1.58
Sex: F
Vaccine: DTAPIPVHIB, HEPA
Symptoms: Wrong product administered
Clinical narrative: Pentacel administered instead of DTaP.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Blood creatinine increased, C-reactive protein increased, COVID-19, COVID-19 pneumonia, Cough
Clinical narrative: Patient diagnosed with Covid-19 on 11.28 - followed by progressive cough, SOB, low oxygen saturation in the 80's with ambulation, presented to ER. Creatinine 2.2 (baseline 0.7), CRP 24.66, Procal 0.58, Ferritin 888, D-Dimer 1.73. Admitted for respiratory failure with hypoxia due to Covid-19 PNA, did not meet criteria for Remdesivir, treated with Decadron and 2 doses of Actemra. Continued to require high-flow oxygen. Discharged on high-flow oxygen.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fibrin D dimer, Hypoxia, Oxygen saturation decreased, Procalcitonin
Clinical narrative: Patient diagnosed with Covid-19 on 11.28 - followed by progressive cough, SOB, low oxygen saturation in the 80's with ambulation, presented to ER. Creatinine 2.2 (baseline 0.7), CRP 24.66, Procal 0.58, Ferritin 888, D-Dimer 1.73. Admitted for respiratory failure with hypoxia due to Covid-19 PNA, did not meet criteria for Remdesivir, treated with Decadron and 2 doses of Actemra. Continued to require high-flow oxygen. Discharged on high-flow oxygen.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory failure, Serum ferritin increased
Clinical narrative: Patient diagnosed with Covid-19 on 11.28 - followed by progressive cough, SOB, low oxygen saturation in the 80's with ambulation, presented to ER. Creatinine 2.2 (baseline 0.7), CRP 24.66, Procal 0.58, Ferritin 888, D-Dimer 1.73. Admitted for respiratory failure with hypoxia due to Covid-19 PNA, did not meet criteria for Remdesivir, treated with Decadron and 2 doses of Actemra. Continued to require high-flow oxygen. Discharged on high-flow oxygen.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dehydration, Hypophagia, Nausea
Clinical narrative: Patient presented to ER with c/o nausea, poor oral intake. Found to have Covid-19 and dehydration. IV Hydration, IV nausea medication. Vitamin supplements.
Age: 51.0
Sex: F
Vaccine: FLU4
Symptoms: Pruritus, Urticaria
Clinical narrative: Itching in face and neck began around 4pm, itching and hives on back and torso began around 5pm, Benadryl po taken to relieve symptoms
Age: 51.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site mass, Injection site rash, Injection site warmth
Clinical narrative: After about 24 hours I experienced a rash and lump at the injection site. It is warm to the touch. It is what has been referred to as "covid" arm on other adverse event reporting. I do believe it is starting to subside at this point.
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Wrong product administered
Clinical narrative: Patient intended to get a flu shot and was administered a Spikevax instead
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Blood creatinine increased, COVID-19 pneumonia, Cardiac failure acute
Clinical narrative: Admitted for diagnosis of acute respiratory failure with hypoxia due to Covid-19 pneumonia. Patient was started on steroid, bronchodilator. Patient creatinine trended up, diagnosed with AKI. Unable to start Remdesivir or baricitinib due to her worsening renal function. Patient deteriorated and was placed on high-flow nasal cannula. Patient progressed to needing continuous BiPaP. Oxygen levels were still in the 80's on BiPaP. Family agreed to transition her to comfort measures only. Soon after patient was put on comfort care, patient passed away. Cause of death is acute respiratory failure due to Covid-19 PNA, complicated by acute on chronic HF, AKI and ILD.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Death, General physical health deterioration, Hypoxia, Interstitial lung disease, Positive airway pressure therapy
Clinical narrative: Admitted for diagnosis of acute respiratory failure with hypoxia due to Covid-19 pneumonia. Patient was started on steroid, bronchodilator. Patient creatinine trended up, diagnosed with AKI. Unable to start Remdesivir or baricitinib due to her worsening renal function. Patient deteriorated and was placed on high-flow nasal cannula. Patient progressed to needing continuous BiPaP. Oxygen levels were still in the 80's on BiPaP. Family agreed to transition her to comfort measures only. Soon after patient was put on comfort care, patient passed away. Cause of death is acute respiratory failure due to Covid-19 PNA, complicated by acute on chronic HF, AKI and ILD.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Renal impairment
Clinical narrative: Admitted for diagnosis of acute respiratory failure with hypoxia due to Covid-19 pneumonia. Patient was started on steroid, bronchodilator. Patient creatinine trended up, diagnosed with AKI. Unable to start Remdesivir or baricitinib due to her worsening renal function. Patient deteriorated and was placed on high-flow nasal cannula. Patient progressed to needing continuous BiPaP. Oxygen levels were still in the 80's on BiPaP. Family agreed to transition her to comfort measures only. Soon after patient was put on comfort care, patient passed away. Cause of death is acute respiratory failure due to Covid-19 PNA, complicated by acute on chronic HF, AKI and ILD.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal wall haematoma, Acute kidney injury, Acute respiratory failure, Anticoagulant therapy, COVID-19
Clinical narrative: Presented to hospital with progressively worsening SOB, tested positive for covid-19. CXR showing Covid PNA. Admitted for acute respiratory failure with hypoxia secondary to Covid-19, AKI on CKD-4. Patient was transferred on 1.30.22 for worsening renal function and dialysis needs. Oxygen requirements remained consistently high through entire length of stay - unable to wean off. Was transferred to ICU for hypotensive shock, chest/abdominal wall hematoma development while on Heparin gtt. Family agreed to comfort care on 2.8.22. Patient was not a candidate for Remdesivir due to renal function. Treated with IV Steroids and Baricitinib at hospital.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Chest wall haematoma, Chronic kidney disease, Dialysis
Clinical narrative: Presented to hospital with progressively worsening SOB, tested positive for covid-19. CXR showing Covid PNA. Admitted for acute respiratory failure with hypoxia secondary to Covid-19, AKI on CKD-4. Patient was transferred on 1.30.22 for worsening renal function and dialysis needs. Oxygen requirements remained consistently high through entire length of stay - unable to wean off. Was transferred to ICU for hypotensive shock, chest/abdominal wall hematoma development while on Heparin gtt. Family agreed to comfort care on 2.8.22. Patient was not a candidate for Remdesivir due to renal function. Treated with IV Steroids and Baricitinib at hospital.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hypotension, Hypoxia, Intensive care, Renal impairment
Clinical narrative: Presented to hospital with progressively worsening SOB, tested positive for covid-19. CXR showing Covid PNA. Admitted for acute respiratory failure with hypoxia secondary to Covid-19, AKI on CKD-4. Patient was transferred on 1.30.22 for worsening renal function and dialysis needs. Oxygen requirements remained consistently high through entire length of stay - unable to wean off. Was transferred to ICU for hypotensive shock, chest/abdominal wall hematoma development while on Heparin gtt. Family agreed to comfort care on 2.8.22. Patient was not a candidate for Remdesivir due to renal function. Treated with IV Steroids and Baricitinib at hospital.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Shock
Clinical narrative: Presented to hospital with progressively worsening SOB, tested positive for covid-19. CXR showing Covid PNA. Admitted for acute respiratory failure with hypoxia secondary to Covid-19, AKI on CKD-4. Patient was transferred on 1.30.22 for worsening renal function and dialysis needs. Oxygen requirements remained consistently high through entire length of stay - unable to wean off. Was transferred to ICU for hypotensive shock, chest/abdominal wall hematoma development while on Heparin gtt. Family agreed to comfort care on 2.8.22. Patient was not a candidate for Remdesivir due to renal function. Treated with IV Steroids and Baricitinib at hospital.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chronic obstructive pulmonary disease, Condition aggravated, Dyspnoea
Clinical narrative: Presented initially with SOB, found to have Covid-19 PNA and COPD exacerbation. Patient was given vitamins, steroids and Remdesivir. Patient was able to wean down from 6L NC to his baseline home o2 at 4L. Patient refused home health and was discharged home.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Ileus, Imaging procedure abnormal
Clinical narrative: Patient was brought to ER after paramedics were called by her family PCP for low 02 sats. Patient had been recently admitted and diagnosed with PNA. Her last admission Covid test had been negative, however, this admission Covid test was positive. Admitted for acute hypoxic respiratory failure secondary to Covid PNA. Patient was given steroids, vitamins, and Remdesivir. Hospitalization complicated by nausea and vomiting, imaging suggestive of ileus. At time of discharge, walk test was done and patient was discharged home on 2L O2.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Oxygen saturation decreased, SARS-CoV-2 test positive, Vomiting, Walking distance test
Clinical narrative: Patient was brought to ER after paramedics were called by her family PCP for low 02 sats. Patient had been recently admitted and diagnosed with PNA. Her last admission Covid test had been negative, however, this admission Covid test was positive. Admitted for acute hypoxic respiratory failure secondary to Covid PNA. Patient was given steroids, vitamins, and Remdesivir. Hospitalization complicated by nausea and vomiting, imaging suggestive of ileus. At time of discharge, walk test was done and patient was discharged home on 2L O2.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Positive airway pressure therapy
Clinical narrative: Admitted with Covid-19 infection with PNA and acute hypoxic respiratory failure. Patient required BiPAP and high-flow nasal cannula but was eventually able to be transitioned to 3L O2 at rest and 4L with activity. Patient received Remdesivir, steroids. Discharged home with home o2.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia
Clinical narrative: Admitted for Covid-19 pneumonia. Treated with dexamethasone and tocilizumab. Patient discharged home on home oxygen.
Age: 52.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Immediate post-injection reaction, Pain, Swelling
Clinical narrative: SORENESS, REDNESS AND SWELLING; patient stated: "it started immediately, was swollen by that evening and now it's about size of flat egg."
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, C-reactive protein increased, COVID-19, Chest X-ray abnormal, Dyspnoea
Clinical narrative: presented with SOB/ + covid PTA x2 days; started zithromax, vitamins and medrol pack PTA; no improvement so advised by PCP to come to ED; CXR with bilat infiltrates: LABs: D-dimer 1.41, CRP 16.20, Ferritin 484.5; Tx: zithromax, maxipime, decadon, eliquis, vit c, rocephin, vit D3, lovenox, singulair, remdesivir, zinc, tocilizumab, minimal O2 supplementation; back to room air at d/c
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Lung infiltration, SARS-CoV-2 test positive, Serum ferritin increased
Clinical narrative: presented with SOB/ + covid PTA x2 days; started zithromax, vitamins and medrol pack PTA; no improvement so advised by PCP to come to ED; CXR with bilat infiltrates: LABs: D-dimer 1.41, CRP 16.20, Ferritin 484.5; Tx: zithromax, maxipime, decadon, eliquis, vit c, rocephin, vit D3, lovenox, singulair, remdesivir, zinc, tocilizumab, minimal O2 supplementation; back to room air at d/c
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Patient's wife states that hours after receiving Comirnaty, that her husband began to experience sporadic hand tremors. Now, a week later, the states that his hand shakes all the time. Patient has an appointment today to see his doctor.
Age: 60.0
Sex: F
Vaccine: FLUR4
Symptoms: Chest discomfort, Dizziness, Erythema, Influenza like illness, Skin warm
Clinical narrative: Left arm  was red and warm to the touch, flu type symptoms, dizziness, and tightness in chest that started today.
Age: 81.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Pyrexia, Vaccination site inflammation, Vaccination site swelling
Clinical narrative: PATIENT PRESENTED WITH SWOLLEN, RED,  INFLAMED CIRLCE NEAR POINT OF VACCINATION.  POINT HAD FEVER AT TIME OF REPORT 10/13/2023 AT 945AM.  PATIENT SAID INFLAMATION AND SWELLING HAD DECREASED OVER PREVIOUS 24 HOURS.  PATIENT'S PRIMARY DOCTOR'S OFFICE WAS NOTIFIED.  PATIENT SCHEDULED FOR OFFICE CHECK AT 10:15AM 10/13/2023
Age: 44.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Anticoagulant therapy, Asthenia, COVID-19, Chest X-ray abnormal, Diabetic ketoacidosis
Clinical narrative: Presented to ED with N/V, weakness, feer and diarrhea; + covid & DKA; CXR clear; Tx: Vit C, rocephin, Vit D3, lovenox, zinc; initially on 2lpm O2; down to room air at time of d/c
Age: 44.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Diarrhoea, Fear, Nausea, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Presented to ED with N/V, weakness, feer and diarrhea; + covid & DKA; CXR clear; Tx: Vit C, rocephin, Vit D3, lovenox, zinc; initially on 2lpm O2; down to room air at time of d/c
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Atelectasis, COVID-19, Chest X-ray normal, Computerised tomogram thorax, Dyspnoea
Clinical narrative: Presented with SOB; + covid:  instituted on oxygen supplementation, nebulizer treatment and respiratory protocol.Tx: Maxipime, Rocephin, eliquis, doxycycline, zinc:  His routine medications for underlying chronic medical conditions were continued.  Patient did not meet criteria for remdesivir and steroid therapy.  He had a follow-up chest x-ray on 02/05/2022 that showed no acute chest disease.  Chest CT obtained on 02/05/2022 showed consolidation in the left lung base likely represents atelectasis. O2 @ room air at d/c.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Lung consolidation, SARS-CoV-2 test positive
Clinical narrative: Presented with SOB; + covid:  instituted on oxygen supplementation, nebulizer treatment and respiratory protocol.Tx: Maxipime, Rocephin, eliquis, doxycycline, zinc:  His routine medications for underlying chronic medical conditions were continued.  Patient did not meet criteria for remdesivir and steroid therapy.  He had a follow-up chest x-ray on 02/05/2022 that showed no acute chest disease.  Chest CT obtained on 02/05/2022 showed consolidation in the left lung base likely represents atelectasis. O2 @ room air at d/c.
Age: 62.0
Sex: M
Vaccine: COVID19, FLUA4, PNC20, RSV, UNK
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: pt was given high dose flu shot instead of regular dose
Age: 26.0
Sex: F
Vaccine: HPV9
Symptoms: Exposure during pregnancy, No adverse event, Wrong product administered
Clinical narrative: Patient was mistakenly given HPV vaccine instead of TDAP vaccine by nurse. Patient is pregnant at the time, expected due date of 12/22/23 and pregnancy complications of uterine fibroid, joint inflammation, antepartum maternal obesity, and anemia affecting pregnancy. Patient was educated that vaccine is not recommended but that limited studies have shown that vaccine does not typically cause complications for newborn. Patient still received TDAP vaccine after education and counseling. No other immediate events or outcomes noted after giving the HPV vaccine.
Age: 19.0
Sex: F
Vaccine: MNQ
Symptoms: Anxiety, Blood pressure decreased, Blood pressure increased
Clinical narrative: Patient was anxious before and after vaccine . Patient blood pressure dropped . Vitals taken multiple times . . BP increased  after 10 minutes .  Continued to monitor patient x 45 minutes.  Patient stated she felt better .
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, COVID-19, Dyspnoea, Post-acute COVID-19 syndrome
Clinical narrative: Presented wtih increasing SOB; dx with covid 1/22/23; Tx with Decadron, maxipime, heparin, eliquis, Rocephin, The pt was admitted to the hospital on  2/9/2022 because of acute hypoxic respiratory failure and post COVID syndrome.  The patient was seen by Pulmonary.  IV steroids increased.  Eliquis was continued.  Decadron 10 mg 3 times a day continued.  Oxygen was gradually weaned.  Patient on 3 L of oxygen now.  Decadron to be slowly tapered 3-4 weeks per pulmonary recommendation.
Age: 63.0
Sex: F
Vaccine: COVID19, RSV
Symptoms: Decreased appetite, Fatigue, Headache, Influenza like illness, Injection site pain
Clinical narrative: Headache, pain at injection sites, fatigue, overall felt like flu (no appetite)
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Blood potassium decreased, COVID-19, Diarrhoea, SARS-CoV-2 test positive
Clinical narrative: Diarrhea likely due to COVID 19 viral infection:  Improving.  Patient tested positive on 02/04/2022.  No apparent respiratory symptoms, saturating well on room air does not in any COVID-19 specific treatment will continue supportive care for diarrhea, patient was having low potassium due to GI losses, improved significantly,
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Computerised tomogram abnormal, Cough, Hypoxia, Respiratory tract congestion
Clinical narrative: Pt presented with pink tinge cough/ chest congestion, hypoxic; CT with Covid PNA pattern, Covid test neg; but treated as Covid based on CT result and symptoms; Did not require COVID specific therapy as he did not require supplemental O2; Did receive supportive care and p.r.n. meds ; rec'd decadron, rocephin, Vit C, and zinc
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative
Clinical narrative: Pt presented with pink tinge cough/ chest congestion, hypoxic; CT with Covid PNA pattern, Covid test neg; but treated as Covid based on CT result and symptoms; Did not require COVID specific therapy as he did not require supplemental O2; Did receive supportive care and p.r.n. meds ; rec'd decadron, rocephin, Vit C, and zinc
Age: 17.0
Sex: F
Vaccine: FLU4, HEPA, HPV9, MNQ
Symptoms: Blood glucose, Dizziness, Loss of consciousness
Clinical narrative: After receiving the HPV vaccine, the patient experienced brief period of dizziness and was told to lie down on the exam room table. Patient had a brief episode of unconsciousness but remained on the table as her mother was standing by her. Vitals were done and blood sugar was taken. After 2-3 minutes the patient sat up and new set of vitals and blood sugar were done. Patient became fully alert and oriented. Vital signs stable. She states she had not eaten anything for breakfast this morning. After a few more minutes, patient states she felt much better. Her mother was in the room with her. Explained to patient's mother that dizziness can sometimes happen after administration of Gardasil vaccine and to contact her if anything changes. Patient's mother agreed, they decided to go home afterwards.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Hepatic enzyme increased, Mental status changes, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: Presented with AMS; dx UTI and Covid +; Tx:  Rocephin, Maxipime, decadron, Vit C, doxycycline, lovenox, zinc; on supplemental O2 up to 6 LPM per NC initially, down to room air at D/C; Rec'd 4 doses of ivermectin per family request; d'ced due to elevated liver enzymes; MD spoke with family as they requested again but MD refused since it is not standard of care
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19 pneumonia, Chest X-ray abnormal, Encephalopathy, Fibrin D dimer
Clinical narrative: The patient tested positive for covid-19 at home on 2/2/22, and originally was stable at home. He had progressive encephalopathy, as well as hypoxia at home and his parents brought him to the emergency room on 2/8/22; admitted for treatment of acute covid pneumonia, with associated hypoxemic respiratory failure.  initiated on IV dexamethasone, as well as remdesivir, on admission CRP was 14.53, Ferritin 194, and D-dimer 0.87; The patient was originally on 2L NC, with brief increase to 6L NC on 2/11. The patient's chest xray was noted to have worsening bilateral infiltrates on 2/11, and he was then treated with one dose of Actemra in addition to other treatments.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Inflammatory marker test, Lung infiltration, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: The patient tested positive for covid-19 at home on 2/2/22, and originally was stable at home. He had progressive encephalopathy, as well as hypoxia at home and his parents brought him to the emergency room on 2/8/22; admitted for treatment of acute covid pneumonia, with associated hypoxemic respiratory failure.  initiated on IV dexamethasone, as well as remdesivir, on admission CRP was 14.53, Ferritin 194, and D-dimer 0.87; The patient was originally on 2L NC, with brief increase to 6L NC on 2/11. The patient's chest xray was noted to have worsening bilateral infiltrates on 2/11, and he was then treated with one dose of Actemra in addition to other treatments.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Serum ferritin normal
Clinical narrative: The patient tested positive for covid-19 at home on 2/2/22, and originally was stable at home. He had progressive encephalopathy, as well as hypoxia at home and his parents brought him to the emergency room on 2/8/22; admitted for treatment of acute covid pneumonia, with associated hypoxemic respiratory failure.  initiated on IV dexamethasone, as well as remdesivir, on admission CRP was 14.53, Ferritin 194, and D-dimer 0.87; The patient was originally on 2L NC, with brief increase to 6L NC on 2/11. The patient's chest xray was noted to have worsening bilateral infiltrates on 2/11, and he was then treated with one dose of Actemra in addition to other treatments.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Asthenia, Fatigue, Feeling cold, Headache
Clinical narrative: Within about 2 or 3 hrs of receiving my latest Covid shot, my arm began to feel sore.  Shortly afterwards,  all my muscles and joints began to ache and I felt very cold even though it was 75 degrees inside. I developed a bad headache (I rarely get headaches) and felt exhausted. I fell asleep on my sofa and woke up 3 hrs later, exhausted and weak, with my heart racing and also feeling nauseous. I was barely able to get to my bed and just collapsed. It felt like a really bad case of the flu with heart palpitations and high heart rate and nausea. I don't recall having such a bad reaction to any of my previous Covid shots (all Moderna shots). At 22 hours after my shot, I'm finally feeling a little better.  This shot was pretty rough.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Influenza like illness, Myalgia, Nausea, Pain in extremity, Palpitations
Clinical narrative: Within about 2 or 3 hrs of receiving my latest Covid shot, my arm began to feel sore.  Shortly afterwards,  all my muscles and joints began to ache and I felt very cold even though it was 75 degrees inside. I developed a bad headache (I rarely get headaches) and felt exhausted. I fell asleep on my sofa and woke up 3 hrs later, exhausted and weak, with my heart racing and also feeling nauseous. I was barely able to get to my bed and just collapsed. It felt like a really bad case of the flu with heart palpitations and high heart rate and nausea. I don't recall having such a bad reaction to any of my previous Covid shots (all Moderna shots). At 22 hours after my shot, I'm finally feeling a little better.  This shot was pretty rough.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Syncope
Clinical narrative: Within about 2 or 3 hrs of receiving my latest Covid shot, my arm began to feel sore.  Shortly afterwards,  all my muscles and joints began to ache and I felt very cold even though it was 75 degrees inside. I developed a bad headache (I rarely get headaches) and felt exhausted. I fell asleep on my sofa and woke up 3 hrs later, exhausted and weak, with my heart racing and also feeling nauseous. I was barely able to get to my bed and just collapsed. It felt like a really bad case of the flu with heart palpitations and high heart rate and nausea. I don't recall having such a bad reaction to any of my previous Covid shots (all Moderna shots). At 22 hours after my shot, I'm finally feeling a little better.  This shot was pretty rough.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Dyspnoea, Fatigue, Sepsis
Clinical narrative: Presented with SOB, fatigue; admitted with sepsis and acute respiratory failure due to COVID19 associated pneumonia. He was started on iv abx, iv steroids and remdesivir.  Also rec'd actemra and lovenox; breathing gradually improved; oxygen was weaned down to 2 L by NC. home oxygen has been arranged.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Chest discomfort, Cough, Dyspnoea, Lung infiltration
Clinical narrative: Presented with 2 weeks SOB/cough/ chest tightness; CXR with patchy infiltrates; Tx: outside of window for remdisivir; zithromax, rocephin, decadron, lovenox; 2-4 LPM supplemental O2; down to room air by d/c
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Aspiration pleural cavity, Asthenia, Atrial fibrillation, COVID-19 pneumonia
Clinical narrative: presents with SOB; previously diagnosed with COVID PNA on 1/7/22 and was previously hospitalized and eventually discharged home but was profoundly weak and unable to get himself out of bed. transferred to Rehab where he was found to be progressively more hypoxemic requiring up to 10L NC. CXR demonstrated worsening bilateral opacities and antibiotics were initiated with cefepime. Pt transferred for higher level of care.  MAJOR EVENTS: 01/30 -- transferred to ICU, intubated  2/10/22 thoracentesis with removal of 1400cc bloody fluid 2/11/22 afib with RVR with rate control with diltiazem  2/13/22 clinical deterioration with increased vasopressor requirement, acute renal fialure             Family elected to transition to comfort care             Assistance from Palliative care
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Dyspnoea, Endotracheal intubation, General physical health deterioration, Hypoxia
Clinical narrative: presents with SOB; previously diagnosed with COVID PNA on 1/7/22 and was previously hospitalized and eventually discharged home but was profoundly weak and unable to get himself out of bed. transferred to Rehab where he was found to be progressively more hypoxemic requiring up to 10L NC. CXR demonstrated worsening bilateral opacities and antibiotics were initiated with cefepime. Pt transferred for higher level of care.  MAJOR EVENTS: 01/30 -- transferred to ICU, intubated  2/10/22 thoracentesis with removal of 1400cc bloody fluid 2/11/22 afib with RVR with rate control with diltiazem  2/13/22 clinical deterioration with increased vasopressor requirement, acute renal fialure             Family elected to transition to comfort care             Assistance from Palliative care